(Q38010064)

26 August 2017

title

Current epidemiology of diabetic retinopathy and diabetic macular edema (English)

1 reference

26 August 2017

1 reference

1 reference

Jie Ding

1

1 reference

26 August 2017

Tien Yin Wong

series ordinal

2

1 reference

26 August 2017

publication date

1 August 2012

1 reference

26 August 2017

published in

Current diabetes report

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

346-354

1 reference

Global prevalence and major risk factors of diabetic retinopathy

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Advances in the medical treatment of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Prevalence of diabetic retinopathy in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The prevalence of and factors associated with diabetic retinopathy in the Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Prevalence of diabetic retinopathy in rural China: the Handan Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Are individuals with diabetes seeing better?: a long-term epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Epidemiology, risk factors and management of paediatric diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Does pregnancy accelerate the rate of progression of diabetic retinopathy?: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Management of diabetic retinopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Systemic management of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

DIRECT new treatments for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Diabetic retinopathy in a multi-ethnic cohort in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Differential association of serum lipids with diabetic retinopathy and diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

21 January 2018

Obesity and eye diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

C-reactive protein, body mass index, and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Apolipoprotein A1 is overexpressed in the retina of diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Intraretinal leakage and oxidation of LDL in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Apolipoprotein measurements: is more widespread use clinically indicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Inflammation in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Diabetic retinopathy and inflammation: novel therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

The role of genetics in susceptibility to diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Heritability of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Heritability of the severity of diabetic retinopathy: the FIND-Eye study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

A systematic meta-analysis of genetic association studies for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Genome-wide meta-analysis for severe diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Replication analysis for severe diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0283-6

Do all prepubertal years of diabetes duration contribute equally to diabetes complications?

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study

1 reference

12 December 2020

Fenofibrate and diabetic retinopathy

1 reference

12 December 2020

Is menarche associated with diabetic retinopathy?

1 reference

12 December 2020

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

12 December 2020

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

1 reference

12 December 2020

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema

1 reference

12 December 2020

Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study

1 reference

12 December 2020

10.1007/S11892-012-0283-6

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1040595292

0 references

1 reference